Picture of Eli Lilly and Co logo

LLY Eli Lilly and Co Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-0.29%
3m+8.75%
6m+5.33%
1yr+61.81%
Volume Change (%)
10d/3m-24.51%
Price vs... (%)
52w High-6.14%
50d MA-0.73%
200d MA+23.52%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)53.21
PEG Ratio (f)2.23
EPS Growth (f)31.38%
Dividend Yield (f)0.72%
Valuation (ttm)IndustryMarket
Price to Book Value66.34
Price to Tang. Bookn/a
Price to Free Cashflown/a
Price to Sales20.94
EV to EBITDA92.3

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital17.59%
Return on Equity48.93%
Operating Margin18.92%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m22,319.524,539.828,318.428,541.434,124.141,403.6351,700.059.69%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+6.15+33.92+2.16+4.57+23.45+23.84+46.67n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Eli Lilly and Co EPS forecast chart

Profile Summary

Eli Lilly and Company is engaged in drug manufacturing businesses. The Company discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes, obesity and other cardiometabolic products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro, Trulicity and Zepbound. Its oncology products include Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh and Taltz. Its neuroscience products include Cymbalta and Emgality. Its other products and therapies include Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States (U.S.), including Puerto Rico, and in Europe and Asia. The Company, through its subsidiary, POINT Biopharma Global Inc., is engaged in radiopharmaceutical discovery, development, and manufacturing, as well as clinical and pre-clinical radioligand therapies in development for the treatment of cancer.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
January 17th, 1901
Public Since
July 9th, 1970
No. of Shareholders
18,871
No. of Employees
43,000
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
us flag iconNew York Stock Exchange
Shares in Issue
950,766,100

LLY Share Price Performance

Upcoming Events for LLY

Q1 2024 Eli Lilly and Co Earnings Release

Q1 2024 Eli Lilly and Co Earnings Call

Eli Lilly and Co Annual Shareholders Meeting

Eli Lilly and Co Annual Shareholders Meeting

Q2 2024 Eli Lilly and Co Earnings Release

Q2 2024 Eli Lilly and Co Earnings Call

Similar to LLY

Picture of Abbvie logo

Abbvie

us flag iconNew York Stock Exchange

Picture of Bausch Health Companies logo

Bausch Health Companies

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Bristol-Myers Squibb Co logo

Bristol-Myers Squibb Co

us flag iconNew York Stock Exchange

Picture of Cardinal Health logo

Cardinal Health

us flag iconNew York Stock Exchange

FAQ